Trove
Sign In Sign Up

Ron Wyden

Person
Mentions
10
Relationships
1
Events
2
Documents
4
Also known as:
Sens. Ron Wyden and Jeff Merkley
Search

Relationship Network

Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons. Drag nodes to reposition. Node size indicates connection count. Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak). Use legend and help buttons in the graph for more guidance.

Event Timeline

Interactive Timeline: Hover over events to see details. Events are arranged chronologically and alternate between top and bottom for better visibility.
1 total relationships
Connected Entity Relationship Type
Strength (mentions)
Documents Actions
person Jeff Merkley
Business associate
5
1
View
Date Event Type Description Location Actions
2019-01-15 N/A Sens. Wyden and Merkley sent a letter to the FDA regarding hemp regulations. Washington D.C. (Implied) View
0005-12-27 N/A Tax Reform Panel Recommendations; Ron Wyden's 'Fair, Flat Tax Act of 2005' is discussed. N/A View

HOUSE_OVERSIGHT_019617.jpg

This document discusses the psychological concept of "confirmation theory," illustrating it with the public's reaction to Lee Harvey Oswald and applying it to the polarized views on Edward Snowden. It also addresses the inherent deception within intelligence agencies, referencing Winston Churchill and citing James Clapper's testimony to the Senate Intelligence Committee regarding NSA data collection.

Book page / report excerpt
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024892.jpg

This document is page 76 of a Cowen Collaborative Insights report dated February 25, 2019. It details regulatory challenges and updates regarding CBD and hemp products, specifically focusing on FDA regulations and state-level legislation in California (Assembly Bill 2914). The document bears a 'HOUSE_OVERSIGHT' footer, suggesting it was part of a document production for a congressional investigation, though the content itself is strictly related to cannabis industry regulation and contains no direct mention of Jeffrey Epstein or his associates.

Financial/regulatory research report (cowen collaborative insights); likely part of a house oversight committee document production.
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_022377.jpg

This document, produced by EY following the 2016 election, provides a profile of expected US Senate committee leadership for the upcoming Congress. It details the chairmen and ranking members for key committees and analyzes the various political scenarios influencing these appointments, such as retirements, term limits, and senators' strategic choices. Despite the prompt's framing, the document's content is purely about US Senate politics and contains no information related to Jeffrey Epstein.

Political analysis report / senate committee profile
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_022336.jpg

This document is a table of contents from a 2013 publication titled 'Tax Topics', listing articles and case summaries from 2004 to 2006. The entries cover a range of U.S. tax law subjects, including estate planning, tax reform acts, and specific IRS rulings and court cases. The document carries a Bates number 'HOUSE_OVERSIGHT_022336', indicating it was part of a larger set of documents produced for a congressional investigation, but its content is exclusively related to tax law and does not mention Jeffrey Epstein or his known associates.

Table of contents for a publication on tax topics
2025-11-19
Analysis Source
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
1
As Recipient
0
Total
1

Update federal regulations governing hemp-derived ingredi...

From: Ron Wyden
To: FDA

Urging the agency to update federal regulations governing the use and interstate sale of certain hemp-derived ingredients.

Letter
2019-01-15
Communication Source

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein entity

Back to Search